Examinando por Materia "Lacticaseibacillus rhamnosus"
Mostrando 1 - 2 de 2
- Resultados por página
- Opciones de ordenación
Ítem Acceso abierto Effect of the use of probiotics (lactobacillus rhamnosus and bifidobacterium longum) in the prevention and control of intestinal dysbiosis. Systematic review.(Universidad Privada Norbert Wiener, 2018-09-24) Vega Bazán, Dayana Joyanne; Bohórquez Medina, Andrea LisbetObjective: To determine the effect of probiotics (lactobacillus and Bifidobacterium) for the prevention and treatment of intestinal dysbiosis in adults. Materials and methods: Systematic review, based on the PRISMA statement and Cochrane Rob 2.0 collaboration. A systematic search was conducted in the databases Scopus, Web of Science, Embase, etc. Ten studies were selected for the final sample. The search strategy was 'Probiotics/intestinal dysbiosis/Clinical uses/Risk and safety/lactobacillus rhamnosus/bifidobacterium longum/Use therapeutic/Gut microbiome.' Results: Of the 10 articles, 9 mentioned probiotic treatments for the symptoms of intestinal dysbiosis (IBS and its subtypes), 2 of the 9 trials included FOS (inulin) in their probiotic composition, and 1 article focused on the treatment against diarrhea caused by Clostridium difficile. Seven out of 10 studies showed significant improvements in abdominal pain, abdominal distension, and intestinal permeability (p<0.01; p<0.01; p=0.01), respectively. Conclusion: The use of probiotics, specifically Lactobacillus rhamnosus and Bifidobacterium longum, used in 9 of 10 analyzed articles, reported a significant reduction (p<0.05) in the clinical symptoms typical of intestinal dysbiosis and also showed a preventive effect in individuals with an unaltered microbiota.Ítem Acceso abierto Review crite: effectiveness of lactobacillus rhamnosus gg as a treatment of acute diarrhea in pediatric age(Universidad Privada Norbert Wiener, 2022-11-25) Pinedo Ramos, Judith Narciza; Palma Gutiérrez, Edgardo JhoffireAcute diarrhea in pediatric age reduces the absorption of nutrients and increases their losses, and can also lead to recurrent infections and thereby deteriorate the child's health. The present secondary research, titled Critical Review: Effectiveness of Lactobacillus rhamnosus GG as a treatment for acute diarrhea in pediatric age, aimed to analyze the effectiveness and rational use of Lactobacillus rhamnosus GG in the treatment of acute diarrhea in pediatric age. The clinical question was: Is the probiotic Lactobacillus rhamnosus GG useful for treating acute diarrhea in pediatric age? The Evidence-Based Nutrition (NuBE) methodology was used. The information search was carried out in the Medline and Cochrane databases, finding 49 articles, 6 articles were selected that were evaluated by the CASPE critical reading tool, finally selecting the systematic review titled: “Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis”, which has a level of evidence I and grade of recommendation A, according to the expertise of the researcher. The critical comment allowed us to conclude that treatment with Lactobacillus rhamnosus GG is capable of reducing acute diarrhea in pediatric age and that its rational use includes: adequate dose (≥ 1010 CFU per day) and time of intervention (before the second day of onset). of symptoms), provided that rotavirus is the causative agent of diarrhea.
